Page last updated: 2024-09-02

bifendate and chalcone

bifendate has been researched along with chalcone in 2 studies

Compound Research Comparison

Studies
(bifendate)
Trials
(bifendate)
Recent Studies (post-2010)
(bifendate)
Studies
(chalcone)
Trials
(chalcone)
Recent Studies (post-2010) (chalcone)
1248432,015221,086

Protein Interaction Comparison

ProteinTaxonomybifendate (IC50)chalcone (IC50)
perilipin-5Homo sapiens (human)4.245
perilipin-1Homo sapiens (human)4.194
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform aHomo sapiens (human)4.2195
Amine oxidase [flavin-containing] AHomo sapiens (human)1.41
Amine oxidase [flavin-containing] BHomo sapiens (human)1.41
Sortase AStreptococcus mutans5

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gu, X; Lai, Y; Ma, Y; Peng, H; Peng, S; Ren, Z; Tang, X; Zhang, Y1
Gu, X; Peng, H; Peng, S; Ren, Z; Zhang, Y1

Other Studies

2 other study(ies) available for bifendate and chalcone

ArticleYear
Synthesis and biological evaluation of bifendate-chalcone hybrids as a new class of potential P-glycoprotein inhibitors.
    Bioorganic & medicinal chemistry, 2012, Apr-15, Volume: 20, Issue:8

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biphenyl Compounds; Cell Line, Tumor; Cell Proliferation; Chalcone; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; K562 Cells; Structure-Activity Relationship

2012
Bifendate-chalcone hybrids: a new class of potential dual inhibitors of P-glycoprotein and breast cancer resistance protein.
    Biochemical and biophysical research communications, 2014, Dec-12, Volume: 455, Issue:3-4

    Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biphenyl Compounds; Chalcone; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; HEK293 Cells; Humans; Inhibitory Concentration 50; Neoplasm Proteins

2014